Matreya/D-erythro-Sphingosine, D9/2079/1 mg
Catalog #:2079Scientific Name:D-erythro-Sphingosine, D9Common Name:15,15,16,16,17,17,18,18,18-D9-2-Amino-octadec-4-ene-1,3-diolEmpirical Formula:C18H28D9NO2SDSView Safety Data SheetData Sheet:View Data SheetFormula Weight:309Unit:1 mgSolvent:noneSource:syntheticPurity:98+%Analytical Methods:TLC, GC, HPLC, identity confirmed by MSSolubility:chloroform, ethanol, methanol, DMSOPhysical Appearance:solidStorage:-20°CDry Ice:NoHazardous:NoLiterature References:1. Magkos, F. and Mittendorfer, B., \"Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humans in vivo” ClinLipidol. Vol. 4 pp. 215–230, 20092. Byun, H. and Bittman, R. Selective deuterium labeling of the sphingoid backbone: facile syntheses of 3,4, 5-trideuterio-d-erythro-sphingosine and 3-deuterio-d-erythro-sphingomyelin” Chem Phys Lipids, Vol. 163(8) pp. 809-813, 20103. A. Merrill, Jr. \"De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway” The Journal of Biological Chemistry, Vol. 277(29) pp.25843–25846, 20024. J. Shayman \"Sphingolipids” Kidney International, Vol. 58 pp. 11-26, 20005. Y. Hannun and R. Bell \"Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses.” Vol. 235:4789 pp. 670, 19876. V. Nava et al. \"Sphingosine Enhances Apoptosis of Radiation-resistant Prostate Cancer Cells” Cancer Research, Vol. 60 pp. 4468-4474, 2000
